文献速递瓣膜外科

二尖瓣术后健康状态恢复轨迹:心脏外科试验网络汇总分析

Quality of life after mitral valve surgery: Results from the Cardiothoracic Surgical Trials Network.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-08-28

该研究汇总3项多中心随机试验的807例二尖瓣手术患者数据,用KCCQ-OS评估健康状态。术后1个月变化不大,6个月显著改善(+18.5分,95%CI 16.9-20.2)并持续至2年;基线KCCQ-OS较低者改善更大,既往卒中/TIA和慢性肺病患者改善较少。

要点

  • 二尖瓣术后健康状态在6个月时显著改善并持续至2年。
  • 基线KCCQ-OS较低者术后2年改善幅度更大。
  • 既往卒中/TIA和慢性肺病患者健康状态改善较少。

核心结论

  • 二尖瓣手术后疾病特异性健康状态在6个月时显著改善并持续至2年,基线健康状态较差者报告的症状、功能和生活质量改善最大。

研究设计与样本

  • 汇总3项多中心随机二尖瓣手术试验的患者级数据,共807例,采用KCCQ-OS评估健康状态,线性混合效应模型分析恢复轨迹及影响因素。

主要发现

  • 术后1个月健康状态变化不大,6个月时KCCQ-OS平均改善+18.5分(95%CI 16.9至20.2),并持续至2年。
  • 基线KCCQ-OS≥75的患者术后1个月初始恶化,6个月时恢复;基线KCCQ-OS<50的患者术后1个月即大幅改善。
  • 多变量模型中,基线KCCQ-OS每低5分,术后2年改善多3.4分(95%CI 1.7至5.1)。
  • 既往卒中或TIA患者KCCQ-OS改善较少(平均变化-5.6分,95%CI -11.2至-0.1),慢性肺病患者改善较少(-7.4分,95%CI -13.5至-1.4)。
  • 女性改善有减少趋势(平均变化-3.2,95%CI -6.5至0.2)。

临床怎么用

  • 可利用上述恢复轨迹和影响因素进行术前个体化沟通,估算症状获益。
  • 对基线健康状态较差者应告知术后可能早期即改善,对基线较好者应告知可能先有短暂恶化再恢复。
  • 对既往卒中/TIA、慢性肺病及女性患者,应讨论健康状态改善可能较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To understand patterns and patient factors associated with health status recovery after mitral valve surgery. METHODS: Patient-level data from 3 multicenter randomized trials of mitral valve surgery were harmonized, with heart failure-specific health status assessed with the Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) Score. Linear mixed-effects models were used to describe health status over time and to explore patient factors associated with health status recovery. RESULTS: The cohort included 807 patients undergoing mitral valve surgery (mean age 67.1 ± 10 years; 29.9% women); repair in 629 (77.9%) and replacement in 178 (22.1%). Before surgery, mean KCCQ-OS scores were 64.8 ± 22.9. There was little change in health status 1 month after surgery but large improvements by 6 months (+18.5 points, 95% CI, 16.9 to 20.2) that was sustained through 2 years. There were differences in recovery trajectories by baseline KCCQ-OS categories; patients with baseline KCCQ-OS ≥75 reported initial worsening at 1 month with recovery by 6 months, whereas patients with baseline KCCQ-OS <50 had large improvements even at 1 month. In the multivariable model, patients with lower baseline KCCQ-OS had significant improvements 2 years after surgery (3.4-point greater improvement, 95% CI, 1.7 to 5.1, for every 5-point lower baseline KCCQ-OS). Patients with prior stroke or transient ischemic attack and those with chronic lung disease had less KCCQ-OS improvements (mean change, -5.6 points; 95% CI, -11.2 to -0.1; -7.4 points; 95% CI, -13.5 to -1.4, respectively), with a trend toward less improvement in women (mean change, -3.2; 95% CI, -6.5 to 0.2). CONCLUSIONS: Disease-specific health status improves significantly by 6 months after mitral valve surgery and is sustained through 2 years, with the greatest improvement in symptoms, function, and quality of life reported by those with worse health status before surgery. These results allow for more informed preoperative discussions with individualized estimations of the symptomatic benefit from surgery.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Patel SG, Spertus JA, Fu Z, et al. Quality of life after mitral valve surgery: Results from the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg. 2025. PMID: 40885466. doi:10.1016/j.jtcvs.2025.08.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。